ScholarIQanswers from OpenAlex
Leo Pharma (Denmark)
InstitutionResearch output, impact & collaborations
Leo Pharma (Denmark) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Leo Pharma (Denmark)?
ScholarIQrecord summary
Leo Pharma (Denmark) is a research organisation in Ballerup Municipality, DK. OpenAlex records 1,459 works and 106,231 citations for it. 499 researchers list it as their most recent affiliation.
How many works does Leo Pharma (Denmark) have?
ScholarIQindexed works
Leo Pharma (Denmark) has 1,459 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Leo Pharma (Denmark) have?
ScholarIQcitation count
Leo Pharma (Denmark) has 106,231 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Leo Pharma (Denmark)?
ScholarIQresearcher count
Leo Pharma (Denmark) has 499 researchers in the ScholarIQ index.
What is the average h-index at Leo Pharma (Denmark)?
ScholarIQavg h-index
Leo Pharma (Denmark) has an average h-index of 8.5 in OpenAlex.
What is the ROR of Leo Pharma (Denmark)?
ScholarIQror
The ROR for Leo Pharma (Denmark) is on the source record.
What is the OpenAlex record for Leo Pharma (Denmark)?
ScholarIQopenalex
The OpenAlex for Leo Pharma (Denmark) is on the source record.
Who are the most-cited researchers behind Leo Pharma (Denmark)?
ScholarIQtop researchers by citations
What are the most-cited papers on Leo Pharma (Denmark)?
ScholarIQmost cited works
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla
Michael A. Mahowald, Federico E. Rey, Henning Seedorf, Peter J. Turnbaugh, Robert S. Fulton, Aye Wollam, Neha Shah, Chunyan Wang, Vincent Magrini, Richard K. Wilson, Brandi L. Cantarel, Pedro M. Coutinho, Bernard Henrissat, Lara W. Crock, Alison Lawlor Russell, Nathan C. VerBerkmoes, Robert L. Hettich, Jeffrey I. Gordon
Multidisciplinary treatment of disability in ehlers–danlos syndrome hypermobility type/hypermobility syndrome: A pilot study using a combination of physical and cognitive‐behavioral therapy on 12 women
Trine Bathen, Anett Bjørnødegård Hångmann, Marie D. Hoff, Liv Øinæs Andersen, Svend Rand‐Hendriksen
Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.
Liv Øinæs Andersen, Martin Erik Nyeland, Fredrik Nyberg
Higher self‐reported severity of atopic dermatitis in adults is associated with poorer self‐reported health‐related quality of life in France, Germany, the U.K. and the U.S.A.
Liv Øinæs Andersen, Martin Erik Nyeland, Fredrik Nyberg
Children with congenital limb deficiency in Norway: issues related to school life and health-related quality of life. A cross-sectional study
Heidi Johansen, Brede Dammann, Liv Øinæs Andersen, Inger-Lise Andresen
How much of the research on Leo Pharma (Denmark) is open access?
ScholarIQopen access share
56%OPEN ACCESS